TCL1A 抗体
(T-Cell Leukemia/lymphoma 1A (TCL1A))
Overexpression of the TCL1 gene in humans has been implicated in the development of mature T cell leukemia, in which chromosomal rearrangements bring the TCL1 gene in close proximity to the T-cell antigen receptor (TCR)-alpha (MIM 186880) or TCR-beta (MIM 186930) regulatory elements (summarized by Virgilio et al., 1998 [PubMed 9520462]). In normal T cells TCL1 is expressed in CD4-/CD8- cells, but not in cells at later stages of differentiation. TCL1 functions as a coactivator of the cell survival kinase AKT (MIM 164730) (Laine et al., 2000 [PubMed 10983986]).[supplied by OMIM, Jul 2010].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| TCL1A 抗体 (AA 2-109) | 人 | 小鼠 Monoclonal |
|
|
|
| TCL1A 抗体 (AA 2-109) | 人 | 小鼠 Monoclonal |
|
|
|
| TCL1A 抗体 (AA 2-109) | 人 | 小鼠 Monoclonal |
|
|
|
| TCL1A 抗体 (AA 2-109) | 人 | 小鼠 Monoclonal |
|
|
|
| TCL1A 抗体 (AA 1-114) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| TCL1A 抗体 (AA 1-114) | 人 | 兔 Polyclonal |
|
|
|
| TCL1A 抗体 (AA 1-114) (APC) | 人 | 兔 Polyclonal |
|
|
|
| TCL1A 抗体 (AA 1-114) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| TCL1A 抗体 (AA 1-114) (PerCP) | 人 | 兔 Polyclonal |
|
|
|
| TCL1A 抗体 (AA 1-114) (PE) | 人 | 兔 Polyclonal |
|
|
|
| Recombinant TCL1A 抗体 (AA 2-109) | 人 | 兔 Monoclonal |
|
|
|
| TCL1A 抗体 (AA 2-109) | 人 | 小鼠 Monoclonal |
|
|
|
| TCL1A 抗体 (AA 2-109) | 人 | 小鼠 Monoclonal |
|
|
|
| TCL1A 抗体 (AA 2-109) | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant TCL1A 抗体 (AA 2-109) | 人 | 兔 Monoclonal |
|
|
|
| Recombinant TCL1A 抗体 (AA 2-109) | 人 | 兔 Monoclonal |
|
|
|
| TCL1A 抗体 (AA 2-109) | 人 | 小鼠 Monoclonal |
|
|
|
| TCL1A 抗体 (AA 2-109) | 人 | 小鼠 Monoclonal |
|
|
|
| TCL1A 抗体 (AA 2-109) | 人 | 小鼠 Monoclonal |
|
|
|
| TCL1A 抗体 (AA 2-109) | 人 | 小鼠 Monoclonal |
|
|
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- TCL1-2078
- 标记
- unconjugated
- 抗体亚型
- IgG1, kappa
- 抗原表位
- AA 2-109
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- WB (Western Blotting: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- TCL1-2079
- 标记
- unconjugated
- 抗体亚型
- IgG2a, kappa
- 抗原表位
- AA 2-109
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- WB (Western Blotting: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- TCL1-2079
- 标记
- unconjugated
- 抗体亚型
- IgG2a, kappa
- 抗原表位
- AA 2-109
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- TCL1-2078
- 标记
- unconjugated
- 抗体亚型
- IgG1, kappa
- 抗原表位
- AA 2-109
Primary Antibody
- EIA (Enzyme Immunoassay: 所列应用)
- RIA (Radioimmunoassay: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗原表位
- AA 1-114
Primary Antibody
- EIA (Enzyme Immunoassay: 所列应用)
- RIA (Radioimmunoassay: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-114
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗原表位
- AA 1-114
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗原表位
- AA 1-114
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PerCP
- 抗原表位
- AA 1-114
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗原表位
- AA 1-114
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- TCL1-2747R
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, kappa
- 抗原表位
- AA 2-109
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- TCL1-2078
- 标记
- unconjugated
- 抗体亚型
- IgG1, kappa
- 抗原表位
- AA 2-109
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- TCL1-2079
- 标记
- unconjugated
- 抗体亚型
- IgG2a, kappa
- 抗原表位
- AA 2-109
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- TCL1-2079
- 标记
- unconjugated
- 抗体亚型
- IgG2a, kappa
- 抗原表位
- AA 2-109
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- TCL1-2747R
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, kappa
- 抗原表位
- AA 2-109
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- TCL1-2747R
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, kappa
- 抗原表位
- AA 2-109
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- TCL1-2078
- 标记
- unconjugated
- 抗体亚型
- IgG1, kappa
- 抗原表位
- AA 2-109
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- TLLP1-1
- 标记
- unconjugated
- 抗体亚型
- IgG1, kappa
- 抗原表位
- AA 2-109
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- TCL1-2079
- 标记
- unconjugated
- 抗体亚型
- IgG2a, kappa
- 抗原表位
- AA 2-109
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- TLLP1-1
- 标记
- unconjugated
- 抗体亚型
- IgG1, kappa
- 抗原表位
- AA 2-109
Latest Publications for our TCL1A 抗体
: "Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation." in: Molecular endocrinology (Baltimore, Md.), Vol. 30, Issue 3, pp. 382-98, (2016) (PubMed).
: "CD34 affinity pheresis attenuates a surge among circulating progenitor cells following vascular injury." in: Journal of vascular surgery, Vol. 59, Issue 6, pp. 1686-94, (2014) (PubMed).
: "Integrated high-power electro-optic lens and large-angle deflector." in: Applied optics, Vol. 40, Issue 31, pp. 5638-42, (2008) (PubMed).
: "Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation." in: The American journal of surgical pathology, Vol. 32, Issue 1, pp. 113-22, (2007) (PubMed).
: "Expression of TCL1 and CD27 in primary cutaneous B-cell lymphomas." in: Histopathology, Vol. 49, Issue 4, pp. 343-8, (2006) (PubMed).
: "Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation." in: Blood, Vol. 108, Issue 6, pp. 1991-8, (2006) (PubMed).
: "Expression of TCL1 in hematologic disorders." in: Pathobiology : journal of immunopathology, molecular and cellular biology, Vol. 69, Issue 2, pp. 59-66, (2001) (PubMed).
: "The role of TCL1 in human T-cell leukemia." in: Oncogene, Vol. 20, Issue 40, pp. 5638-43, (2001) (PubMed).
: "Activation of the TCL1 protein in B cell lymphomas." in: Pathology international, Vol. 50, Issue 3, pp. 191-9, (2000) (PubMed).
: "Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues." in: Cancer research, Vol. 60, Issue 8, pp. 2095-100, (2000) (PubMed).
: "CD34 affinity pheresis attenuates a surge among circulating progenitor cells following vascular injury." in: Journal of vascular surgery, Vol. 59, Issue 6, pp. 1686-94, (2014) (PubMed).
: "Integrated high-power electro-optic lens and large-angle deflector." in: Applied optics, Vol. 40, Issue 31, pp. 5638-42, (2008) (PubMed).
: "Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation." in: The American journal of surgical pathology, Vol. 32, Issue 1, pp. 113-22, (2007) (PubMed).
: "Expression of TCL1 and CD27 in primary cutaneous B-cell lymphomas." in: Histopathology, Vol. 49, Issue 4, pp. 343-8, (2006) (PubMed).
: "Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation." in: Blood, Vol. 108, Issue 6, pp. 1991-8, (2006) (PubMed).
: "Expression of TCL1 in hematologic disorders." in: Pathobiology : journal of immunopathology, molecular and cellular biology, Vol. 69, Issue 2, pp. 59-66, (2001) (PubMed).
: "The role of TCL1 in human T-cell leukemia." in: Oncogene, Vol. 20, Issue 40, pp. 5638-43, (2001) (PubMed).
: "Activation of the TCL1 protein in B cell lymphomas." in: Pathology international, Vol. 50, Issue 3, pp. 191-9, (2000) (PubMed).
: "Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues." in: Cancer research, Vol. 60, Issue 8, pp. 2095-100, (2000) (PubMed).
Aliases for TCL1A 抗体
T-cell leukemia/lymphoma 1A (TCL1A) 抗体T cell lymphoma breakpoint 1 (Tcl1) 抗体
T-cell leukemia/lymphoma 1A (Tcl1a) 抗体
TCL1 抗体
Tcl1 抗体
TCL1A 抗体
Tcl1a 抗体
您还需要查找其他产品吗？
You are here:
